Evaluation of two homogeneous methods for measuring high-density lipoprotein cholesterol

被引:0
|
作者
Huang, YC
Kao, JT
Tsai, KS
机构
[1] NATL TAIWAN UNIV HOSP,COLL MED,DEPT LAB MED,TAIPEI 10016,TAIWAN
[2] NATL TAIWAN UNIV,COLL MED,SCH MED TECHNOL,TAIPEI 10016,TAIWAN
[3] MUNICIPAL HO PIN HOSP,DEPT LAB MED,TAIPEI,TAIWAN
关键词
methods comparison; triglycerides; atherosclerosis;
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
We evaluated the performance of two homogeneous assays for quantifying HDL cholesterol (HDL-C) and compared them with the phosphotungstic acid (PTA)/MgCl2 assay. Both homogeneous HDL-C assays were precise, having a within-run CV of <1.20% and a between-run CV of <4.07%. The HDL-C values (y) measured by the two homogeneous methods correlated well with those by the PTA/MgCl2 method (x): y = 1.00x + 64.98 mg/L, r = 0.987, S-y/x = 27.99 mg/L (n = 152) for the polyethylene glycol-modified enzymes/alpha-cyclodextrin sulfate (PEGME) assay (Kyowa), and y = 0.84x + 106.51 mg/L, r = 0.984, S-y/x = 26.10 mg/L (n = 152) for the polyanion-polymer/detergent (PPD) assay (Daiichi). The specificity of the PEGME method seemed better than that of the PPD method, as the PPD method was markedly interfered with by supplemental LDL-C. Addition of 20 g/L triglycerides produced a negative error of similar to 18% in both homogeneous assays. Bilirubin and hemoglobin had little influence on the PEGME method; hemoglobin had little effect on the PPD method. Bilirubin, however, markedly decreased the readings by the PPD method. We found the PEGME assay superior to the PPD assay for routine HDL-C testing, because the PPD assay is relatively inaccurate and not specific.
引用
收藏
页码:1048 / 1055
页数:8
相关论文
共 50 条
  • [21] HIGH-DENSITY LIPOPROTEIN CHOLESTEROL - SIGNIFICANT BIAS BETWEEN METHODS
    PRIEST, JB
    MOOREHEAD, WR
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1980, 73 (01) : 147 - 147
  • [22] Evaluation of Monocyte to High-Density Lipoprotein Cholesterol and Neutrophil to High-Density Lipoprotein Cholesterol Ratios as Indicators of Inflammation in Patients with Celiac Disease
    Duzenli, Tolga
    Koseoglu, Derya
    Koseoglu, Huseyin
    ERCIYES MEDICAL JOURNAL, 2022, 44 (03) : 274 - 278
  • [23] Evaluation of homogeneous high-density lipoprotein cholesterol assay on a BM/Hitachi 747-200 analyzer
    Lin, MJ
    Hoke, C
    Ettinger, B
    CLINICAL CHEMISTRY, 1998, 44 (05) : 1050 - 1052
  • [24] Evaluation of a homogeneous assay for high-density lipoprotein cholesterol:: limitations in patients with cardiovascular, renal, and hepatic disorders
    Simó, JM
    Castellano, I
    Ferré, N
    Joven, J
    Camps, J
    CLINICAL CHEMISTRY, 1998, 44 (06) : 1233 - 1241
  • [25] SIGNIFICANCE OF HIGH-DENSITY LIPOPROTEIN CHOLESTEROL
    THOMPSON, P
    BORTZ, WM
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1978, 26 (10) : 440 - 442
  • [26] CHOLESTEROL, HIGH-DENSITY LIPOPROTEIN AND DANAZOL
    ALLEN, JK
    FRASER, IS
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1981, 53 (01): : 149 - 152
  • [27] HYPERBILIRUBINEMIA AND HIGH-DENSITY LIPOPROTEIN CHOLESTEROL
    NANJI, AA
    REDDY, S
    ANNALS OF INTERNAL MEDICINE, 1982, 97 (05) : 786 - 786
  • [28] DETERMINANTS OF HIGH-DENSITY LIPOPROTEIN CHOLESTEROL
    KULLER, L
    HULLEY, S
    VOGT, T
    NEATON, J
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1981, 114 (03) : 443 - 443
  • [29] HIGH-DENSITY LIPOPROTEIN CHOLESTEROL IN DIABETES
    MATTOCK, MB
    FULLER, JH
    BRITISH MEDICAL JOURNAL, 1978, 2 (6153): : 1717 - 1717
  • [30] High-density lipoprotein cholesterol and carcinogenesis
    Tan, Meijuan
    Yang, Shijie
    Xu, Xiequn
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2023, 34 (05): : 303 - 313